Validation study demonstrates noninferior diagnostic accuracy with sham-AI assistance among radiologists evaluating intracranial aneurysms, suggesting a viable placebo control to mitigate bias.
Radiologists assisted by the proposed sham–artificial intelligence (AI) model, acting as a placebo control for a standard-AI model to mitigate biases in intracranial aneurysm diagnosis, had noninferior sensitivity and specificity compared with radiologists alone.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: